N2Growth Blog

FEBRUARY 10, 2021

Genentech is a global biotechnology company that created an entire drug discovery industry. We invite you to share your story and get feedback from iconic leaders like Alexander Hardy, executive advisors , top leadership professors, and gifted students from around the world. Genentech has been wildly successful.

Tacit Knowledge 376

Tacit Knowledge Biotechnology Sports Wilde 376

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop.

Bureaucracy 232

Bureaucracy Compliance Learning-by-Doing Engineering 232

The Horizons Tracker

NOVEMBER 29, 2023

“Noting the benefits of diverse experiences in the board room, corporate executives can search beyond the tradition director pedigree (e.g. Moderna, a prominent pharmaceutical and biotechnology firm, adopted an unconventional approach utilizing RNA technology to develop one of the COVID-19 vaccines.

Diversity 112

Diversity Innovation Biotechnology Short-term 112

Harvard Business Review

MARCH 2, 2012

HBS welcomes 6,360 foreign nationals (64% of the total) to its executive education courses each year, enriching the experiences for Americans as well. As a consequence, these foreign-born executives become more interested in doing business with American companies and many will eventually work in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. My first priority was to execute a new strategy that focused the company on rare diseases by repurposing assets in our pipeline. Accordingly, I transformed the business model ?

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

FEBRUARY 22, 2017

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., The industry breakdowns were determined using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g.,

Telecommunications 8

Telecommunications Health Care Contingency Plans Biotechnology 8

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JUNE 21, 2013

This is especially true in the high-growth materials sector, which is executing most poorly on many talent management practices. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., But too many don''t, according to our research. chemicals, metals & mining, paper & forest products).

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Jason Jaroslav Cook Creative/Getty Images.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JUNE 3, 2013

What more should boards be doing to implement and consistently execute effective succession practices? pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Is P&G no longer an academy company? Why are so many companies struggling with a crisis of their leadership bench?

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

MARCH 28, 2012

But the killer was the Sprint culture, which led Nextel executives to leave soon after the merger, dissipating Nextel's relatively more entrepreneurial influence. In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

MAY 10, 2016

As our research has shown us, the core of the problem is not the high number of M&A deals in itself, but rather that too many executives bring insufficient discipline to the evaluation process that fuels these deals — as a result, they often get deals wrong.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Life science company executives need to be thinking about what business they want to be in. They’re also sharing risk. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. I remember sitting there and saying, 'There's got to be a another way.'".

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

FEBRUARY 16, 2016

Boards are clearly aligned with business leaders and executives on their outlooks for 2016. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., If their projections turn out to be right, we should get ready for a bumpy road ahead, with market volatility and negative surprises.

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Once they find it, they work on finding radical ideas and developing business proposals for top executives to review.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JULY 16, 2013

Both boards are on to a good start — demonstrating that when a firm builds a board using a rigorous assessment of the qualities it needs to carry out its governance task, rather than personal networks, the board is better equipped to execute its functions. In our survey, we also asked about specific skills.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. facility in Cambridge Science Park. Decentralize and empower global R&D units.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

FEBRUARY 19, 2015

” An idea is certainly a promising start, but executing it while holding down a busy fulltime job is undoubtedly a challenge. ” Kate left her job at PerkinElmer in February 2014; the next month, she and her business partner started ORIGƷN, a Boston-based biotechnology company. “I made the right decision.

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

FEBRUARY 3, 2015

When I ask my executive students this question, most of them answer in the fours and fives. On average, my executive students answer this question in the twos and threes. That’s fine if an executive is looking to move elsewhere, as some of my participants were. My guess is that your second number is lower than your first.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

NOVEMBER 29, 2016

Historically, the pharmaceutical industry has recruited SAS programmers who have executed well-defined analyses of clinical trials in a standardized, efficient manner. It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 30, 2017

Looking at the executive teams we work with as consultants and those we teach in the classroom, increased diversity of gender, ethnicity, and age is apparent. Throughout this period, we have run a strategic execution exercise with executive groups focused on managing new, uncertain, and complex situations.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

MAY 28, 2013

They are realizing it can no longer solely be the charge of HR executives or even of the CEO and top management — and that they must integrate talent management with the long-term strategic goals of the organization if they are to have any hope of claiming competitive advantage. chemicals, metals & mining, paper & forest products).

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

AUGUST 4, 2016

Yet executive and professional women consistently experience more stress, anxiety, and psychological distress than do men. In one study, female and male MBA students were paired and asked to negotiate the purported purchase of a biotechnology plant. Everyone in today’s supercharged workplaces experiences stress.

Stress 8

Stress Biotechnology Self-aware Resources 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. has been an innovation superpower. Other nations may challenge in one field or another, but no one can match its depth and breadth.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8